Nucleoside analogue

This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (December 2009) (Learn how and when to remove this template message)

This article may be expanded with text translated from the corresponding article in German. (December 2020) Click [show] for important translation instructions. View a machine-translated version of the German article. Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia. Consider adding a topic to this template: there are already 6,968 articles in the main category, and specifying|topic= will aid in categorization. Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing German Wikipedia article at [[:de:Nukleosid-Analogon]]; see its history for attribution. You should also add the template {{Translated|de|Nukleosid-Analogon}} to the talk page. For more guidance, see Wikipedia:Translation.

The antiviral drug aciclovir (bottom), a nucleoside analogue that functions by mimicking guanosine (top)

Nucleoside analogues are nucleosides which contain a nucleic acid analogue and a sugar. Nucleotide analogs are nucleotides which contain a nucleic acid analogue, a sugar, and a phosphate groups with one to three phosphates.

Nucleoside and nucleotide analogues can be used in therapeutic drugs, include a range of antiviral products used to prevent viral replication in infected cells. The most commonly used is acyclovir, although its inclusion in this category is uncertain, because it acts as a nucleoside but contains no actual sugar, as the sugar ring is replaced by an open-chain structure.

Nucleotide and nucleoside analogues can also be found naturally. Examples include ddhCTP (3ʹ-deoxy-3′,4ʹdidehydro-CTP) produced by the human antiviral protein viperin^[1] and (a S-Adenosyl methionine analogue) procduced by some Streptomyces.^[2]

Function[]

These agents can be used against hepatitis B virus, hepatitis C virus, herpes simplex, and HIV. Once they are phosphorylated, they work as antimetabolites by being similar enough to nucleotides to be incorporated into growing DNA strands; but they act as and stop viral DNA polymerase. They are not specific to viral DNA and also affect mitochondrial DNA. Because of this they have side effects such as bone marrow suppression.

There is a large family of nucleoside analogue reverse transcriptase inhibitors, because DNA production by reverse transcriptase is very different from normal human DNA replication, so it is possible to design nucleoside analogues that are preferentially incorporated by the former. Some nucleoside analogues, however, can function both as NRTIs and polymerase inhibitors for other viruses (e.g., hepatitis B).

Less selective nucleoside analogues are used as chemotherapy agents to treat cancer, e.g. gemcitabine. They are also used as antiplatelet drugs to prevent the formation of blood clots, ticagrelor and cangrelor.

Resistance[]

Resistance can develop quickly with as little as one mutation.^[3] Mutations occur in the enzymes that phosphorylate the drug and activate it: in the case of herpes simplex, resistance to acyclovir arises due to a mutation affecting the viral enzyme . Since nucleoside analogues require two phosphorylations to be activated, one carried out by a viral enzyme and the other by enzymes in the host cell, mutations in viral thymidine kinase interfere with the first of these phosphorylations; in such cases the drug remains ineffective. There are, however, several different nucleoside analogue drugs and resistance to one of them is usually overcome by switching to another drug of the same kind (e. g. famciclovir, penciclovir, valaciclovir).

Examples[]

Nucleoside analogue drugs include:

• deoxyadenosine analogues:
  • didanosine (ddI)(HIV)
  • vidarabine (antiviral)
• adenosine analogues:
  • galidesivir (Ebola)
  • remdesivir (Ebola)(Marburg)(Coronavirus)
• deoxycytidine analogues:
  • cytarabine (chemotherapy)
  • gemcitabine (Chemotherapy)
  • emtricitabine (FTC)(HIV)
  • lamivudine (3TC)(HIV, hepatitis B)
  • zalcitabine (ddC)(HIV)
• guanosine and deoxyguanosine analogues:
  • abacavir (HIV)
  • aciclovir
  • entecavir (hepatitis B)
• thymidine and deoxythymidine analogues:
  • stavudine (d4T)
  • telbivudine (hepatitis B)
  • zidovudine (azidothymidine, or AZT)(HIV)
• deoxyuridine analogues:
  • idoxuridine
  • trifluridine

Related drugs are nucleobase analogs, which don't include a sugar or sugar analog, and nucleotide analogues, which also include phosphate groups.

See also[]

• For nucleoside analogues in biology, see nucleic acid analogues

Antibiotics[]

Nucleoside antibiotics are a class of antibiotics that inhibit the MraY enzyme (phospho-N-acetylmuramoyl-pentapeptide translocase) in peptidoglycan biosynthesis pathway of mycobacteria, gram positive and gram negative strains.^[4]

References[]